Literature DB >> 29951964

C3 glomerulopathy in NLRP12-related autoinflammatory disorder: case-based review.

Özge Başaran1, Nermin Uncu2, Nilgün Çakar3, Eda Tahir Turanlı4, Saba Kiremitci5, Fatma Aydın2, Umut Selda Bayrakcı6.   

Abstract

Autoinflammatory diseases (AIDs) are a recently described group of conditions caused by mutations in multiple genes that code for proteins of the innate immune system. Cryopyrin-associated periodic syndromes (CAPS) are autoinflammatory diseases comprising three clinically overlapping disorders: familial cold urticarial syndrome (FCAS), Muckle-Wells syndrome (MWS), and neonatal-onset multisystem inflammatory disease (NOMID). CAPS have been associated with gain-of-function variations in NLRP3 (NOD-like receptor family, pyrin containing domain-3). However, a new class of autoinflammatory disease resembling FCAS or MWS has been described in patients with NLRP12 mutations. Here, we report a 6-year-old boy diagnosed with AID who developed an unexpected C3 glomerulopathy during attacks and carried a novel variation in NLRP12. Following treatment with IL (interleukin) 1 targeting agents, all symptoms and inflammation resolved. This is the first case in the literature affected by both autoinflammatory disease and C3 glomerulopathy.

Entities:  

Keywords:  Autoinflammatory disease; C3 glomerulopathy; NLRP12; Pediatric

Mesh:

Substances:

Year:  2018        PMID: 29951964     DOI: 10.1007/s00296-018-4092-3

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  17 in total

1.  F402L variant in NLRP12 in subjects with undiagnosed periodic fevers and in healthy controls.

Authors:  Carlo De Pieri; Josef Vuch; Emmanouil Athanasakis; Giovanni Maria Severini; Sergio Crovella; Anna Monica Bianco; Alberto Tommasini
Journal:  Clin Exp Rheumatol       Date:  2014-10-20       Impact factor: 4.473

2.  Role of interleukin-1β in NLRP12-associated autoinflammatory disorders and resistance to anti-interleukin-1 therapy.

Authors:  Isabelle Jéru; Véronique Hentgen; Sylvain Normand; Philippe Duquesnoy; Emmanuelle Cochet; Adriana Delwail; Gilles Grateau; Sandrine Marlin; Serge Amselem; Jean-Claude Lecron
Journal:  Arthritis Rheum       Date:  2011-07

Review 3.  The NLRP3 inflammasome in kidney disease and autoimmunity.

Authors:  Holly L Hutton; Joshua D Ooi; Stephen R Holdsworth; A Richard Kitching
Journal:  Nephrology (Carlton)       Date:  2016-09       Impact factor: 2.506

4.  Multigene sequencing reveals heterogeneity of NLRP12-related autoinflammatory disorders.

Authors:  Mikhail M Kostik; Evgeny N Suspitsin; Marina N Guseva; Anastasia S Levina; Anastasia Y Kazantseva; Anna P Sokolenko; Evgeny N Imyanitov
Journal:  Rheumatol Int       Date:  2018-03-02       Impact factor: 2.631

5.  Diagnostics and therapeutic insights in a severe case of mevalonate kinase deficiency.

Authors:  Marco Nevyjel; Alessandra Pontillo; Lorenzo Calligaris; Alberto Tommasini; Andrea D'Osualdo; Hans R Waterham; Marilena Granzotto; Sergio Crovella; Egidio Barbi; Alessandro Ventura
Journal:  Pediatrics       Date:  2007-01-29       Impact factor: 7.124

6.  Rare NLRP12 variants associated with the NLRP12-autoinflammatory disorder phenotype: an Italian case series.

Authors:  Antonio Vitale; Donato Rigante; Maria Cristina Maggio; Giacomo Emmi; Micol Romano; Elena Silvestri; Orso Maria Lucherini; Lorenzo Emmi; Valeria Gerloni; Luca Cantarini
Journal:  Clin Exp Rheumatol       Date:  2013-09-09       Impact factor: 4.473

7.  Periodic fever syndrome with relapsing glomerulonephritis: a case report and teaching points.

Authors:  Mykola V Tsapenko; Timothy G Call; John A Lust; Nelson Leung
Journal:  NDT Plus       Date:  2011-07-06

Review 8.  The "other" vasculitis syndromes and kidney involvement.

Authors:  Seza Ozen
Journal:  Pediatr Nephrol       Date:  2009-11-07       Impact factor: 3.714

Review 9.  The NLRP3 and Pyrin Inflammasomes: Implications in the Pathophysiology of Autoinflammatory Diseases.

Authors:  Carlos de Torre-Minguela; Pablo Mesa Del Castillo; Pablo Pelegrín
Journal:  Front Immunol       Date:  2017-01-27       Impact factor: 7.561

10.  Identification of a Novel NLRP12 Nonsense Mutation (Trp408X) in the Extremely Rare Disease FCAS by Exome Sequencing.

Authors:  Xiaoru Xia; Caijun Dai; Xiaochun Zhu; Qiumei Liao; Xu Luo; Yangyang Fu; Liangxing Wang
Journal:  PLoS One       Date:  2016-06-17       Impact factor: 3.240

View more
  1 in total

Review 1.  NLRP12-associated systemic autoinflammatory diseases in children.

Authors:  Hui-Fang Wang
Journal:  Pediatr Rheumatol Online J       Date:  2022-02-05       Impact factor: 3.054

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.